Nifty extended its winning streak, surpassing a key resistance level, but analysts foresee challenges around 25,500-25,670. Despite potential headwinds from US visa policy changes impacting the IT sector, technical indicators suggest a bullish outlook. Experts advise traders to capitalize on dips, highlighting Samman Capital and Piramal Pharma as potential buys with specific targets and stop-loss levels.
IDBI Bank Q2 results: Net profit tanks 39% YoY to Rs 2,205 crore; NII dips 49% YoY
IDBI Bank reported a 39% year-on-year profit decline to Rs 2,205 crore in Q2 FY27, impacted by a one-off gain in the previous year. Excluding